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Prospective Measurement 
of Function and Pain in 
Patients with Non-Neoplastic 
Compression Fractures 
Treated with Vertebroplasty
BY HEIDI PRATHER, DO, LINDA VAN DILLEN, PT, PHD, 
JOHN P. METZLER, MD, K. DANIEL RIEW, MD, AND LOUIS A. GILULA, MD
Investigation performed at Washington University School of Medicine, St. Louis, Missouri 
Background: There has been an increasing number of reports regarding the benefits of vertebroplasty for the treat-
ment of vertebral compression fractures. In this investigation, validated outcome tools were utilized to document the
impact of vertebroplasty on pain and function.
Methods: Fifty patients were recruited at a tertiary university hospital. Patients had been treated for intractable pain
due to osteoporotic compression fracture(s) for at least four weeks. The vertebroplasty procedures were performed
by a radiologist. The subjects were followed prospectively for one year and received conservative treatment in con-
junction with the vertebroplasty. Validated outcome tools, including a visual analog scale, the Oswestry scale, and
the Roland-Morris functional activity questionnaire, were used to evaluate changes in pain and functional capabilities.
Results: Fifty patients, thirty-one women and nineteen men (mean age, 68.6 years), were followed prospectively
for one year. One hundred and three fractures (fifty-nine thoracic and forty-four lumbar) were treated. The visual an-
alog scale showed the greatest improvement between the baseline score (mean, 7.76) and the score at one
month (mean, 2.9), and the score remained improved at one year (mean, 2.9). The Oswestry and Roland-Morris
questionnaires demonstrated significant (p < 0.0001) functional improvement between the baseline and one-
month scores. With the numbers available, there were no significant changes in any variable from one month to
one year (p > 0.05).
Conclusions: Vertebroplasty is an effective treatment for patients with intractable pain due to osteoporotic vertebral
compression fractures. Improvement in pain scores and functional capabilities that were found at one month were
maintained at one year.
Level of Evidence: Therapeutic Level IV. See Instructions to Authors for a complete description of levels of evidence.
steoporotic vertebral compression fractures can cause
substantial impairment and disability. These frac-
tures often do not require hospitalization but can re-
quire months to heal. Conservative management, including
analgesics, therapeutic modalities, bracing, and exercise, usu-
ally facilitates healing and pain relief within four to eight
weeks. However, some individuals do not respond to con-
servative treatment and go on to have intractable pain. Op-
erative management of vertebral compression fractures is
generally reserved for patients with spinal deformity or neu-
rological compromise. Surgery is often viewed as a last resort
because of the high rate of coexisting morbidities, poor fu-
sion rates secondary to difficulty in obtaining purchase for
implants in osteoporotic bone, and reduced osteogenesis in
the elderly1. In addition, acute complications such as tran-
sient ileus, urinary retention, and occasionally spinal cord
compression can occur2,3. Chronic effects include kyphosis
with occasional breathing difficulties, deconditioning, insom-
nia, and depression.
Vertebroplasty, which is the percutaneous infusion of
polymethylmethacrylate into the compressed vertebra, is an
alternative treatment for patients with intractable pain due to
O
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osteoporotic compression fracture(s)3-5. The purpose of the
procedure is to relieve pain by reinforcing the fractured verte-
bra. Early relief of pain may be expected to improve function
as well, ultimately reducing impairment and disability. This
should place elderly individuals at less risk for subsequent
health complications as a result of immobilization. Several
reports2,3,6-8 have described the technical aspects of vertebro-
plasty for osteoporotic fractures and the pain relief reported
by patients treated with the procedure. The outcomes de-
scribed in these studies include changes in mobility and usage
of analgesic medication. A number of the studies4,8,9 included
patients who were treated with vertebroplasty for fractures re-
lated to a tumor. Patients with cancer and those with os-
teoporosis may report pain differently as a result of factors
unrelated to the fracture. It is possible that patients with can-
cer do not have the same level of functional improvement as
patients with non-neoplastic vertebral fracture. To our knowl-
edge, no one has used validated outcome measures to deter-
mine the functional improvements in conjunction with the
pain relief in patients treated with vertebroplasty for os-
teoporotic fracture. The purpose of the current study was to
determine if vertebroplasty can offer patients with intractable
pain related to osteoporotic compression fracture pain relief
and improved function.
Materials and Methods
ifty-two consecutive patients with non-neoplastic verte-
bral compression fracture(s) were prospectively enrolled
in the study. Two of those patients decided not to answer the
questionnaires completely after enrolling and were not in-
cluded in the study. An additional (fifty-third) patient lived a
substantial distance from our center and did not want to re-
ceive follow-up there and thus had declined to be enrolled.
The procedure, including the potential benefits and
risks, was discussed with the patient. The potential complica-
tions of vertebroplasty that were described included bleeding,
bone infection or fracture, damage to nerve roots or the spinal
cord, leakage of material into the surrounding epidural or
paravertebral spaces, and passage of material into the venous
system with embolization to the pulmonary vasculature or
compression of neural tissues. The participants then signed
two written informed-consent forms, one for the procedure
and one to enroll in the study. The study received institutional
review board approval through the Human Studies Commit-
tee at Washington University School of Medicine.
Conservative management, lasting for at least four
weeks and including pain medication(s), bed rest, bracing,
and therapeutic exercise directed by a physical therapist, had
failed for all patients. The appropriateness of the vertebro-
plasty for each patient was determined by a group of physi-
cians practicing in four different disciplines, including two
physiatrists, one neurosurgeon, one radiologist, and three or-
thopaedic spine surgeons, in a university-based hospital set-
ting. The physiatrists or referring spine surgeon provided
evaluation and treatment prior to the procedure. Follow-up
care was provided by the physiatrists. The follow-up question-
naires were returned by the patient at the time of follow-up or
were administered by telephone by a research assistant trained
in telephone interview techniques. The radiologist had exten-
sive experience with vertebroplasty and performed or was in-
volved in all of the procedures. One of the spine surgeons
reviewed all questionable imaging studies to confirm spinal
stability and to help determine whether the patient was a can-
didate for surgery or vertebroplasty. Magnetic resonance im-
aging was utilized to assess acuity and other characteristics of
the fracture, patency of the spinal canal, and disc abnormali-
ties. All patients in this study had decreased signal on T1-
weighted images and increased signal on T2-weighted images
of the compressed vertebra, indicating an acute or subacute
fracture, and the compression fractures were confirmed by the
radiologist. No burst fractures that included the posterior ele-
ments were included in this study. Computed tomography
was not routinely performed, and the status of the posterior
wall of the vertebral body was not used to determine a pa-
tient’s eligibility for the vertebroplasty.
A history was recorded and a physical examination was
performed for all patients to determine if the compression
fracture correlated with the symptoms. In addition to a full
neurological and musculoskeletal examination, the patient
was asked to flex and extend the spine to its end range of mo-
tion in order to provoke pain. If pain was elicited at the site of
the fracture, the provocative test was considered to be positive.
Flexion loads the fractured vertebra and usually causes pain in
the acute setting. Extension may cause pain as well, especially
when a retropulsed fragment is in the spinal canal. We specu-
lated that this may elicit osseous as well as neurogenic pain as
the canal is narrowed with extension. If there was an adjacent-
level fracture(s) that correlated with the site of pain, all of the
fractures were treated. If a fracture was noted at a distance
from the site of pain and pain could not be provoked on phys-
ical examination, that fracture was not treated. Patients were
followed for a minimum of one year by one of the two physia-
trists, neither of whom had performed the procedure.
The patient completed a baseline questionnaire, which
included information regarding general health, previous med-
ical care for osteoporosis, and previous conservative manage-
ment for the pain due to vertebral compression fracture(s).
Laboratory work, including a complete blood-cell count,
platelet count, measurement of the prothrombin time, and
measurement of the partial thromboplastin time, was done to
rule out bleeding disorders. A standardized physical examina-
tion that included the neurological and musculoskeletal sys-
tems was performed by one of the surgeons or physiatrists.
The multidisciplinary group of physicians reviewed the case of
each patient who was being considered for vertebroplasty. All
imaging studies pertaining to the area of pain were reviewed
and were compared with the history and the findings of the
physical examination. At a minimum, imaging included fron-
tal and lateral spine radiographs and magnetic resonance im-
aging, unless the patient could not have magnetic resonance
imaging, in which case a computed tomography scan with or
without bone scintigraphy was performed. Inclusion and ex-
F
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clusion criteria for offering patients a vertebroplasty are listed
in Table I.
The vertebroplasty was performed by the radiologist as
described by Jensen et al.3 and as modified by the radiologist.
A unipedicular approach was used more commonly than a
bipedicular approach. Osteobond copolymer bone cement
(Zimmer, Warsaw, Indiana) was injected. The blood pressure,
heart rate, and result of pulse oximetry were monitored and
oxygen was supplied through a nasal cannula throughout the
procedure. A nurse trained in conscious sedation adminis-
tered neuroleptic analgesics (fentanyl and midazolam) under
the direction of the radiologist. A transpedicular approach
with an 11-gauge Jamshidi-type needle (MD Tech Bone Bi-
opsy Set; Medical Devices Technology, Gainesville, Florida)
was used. A technically successful procedure was defined by an
effective transpedicular puncture of the vertebral body with
instillation of bone cement. The amount of bone cement that
was injected and any complications were recorded.
The outcome tools were administered by individuals
other than the physician performing the procedure to limit
patient-reporting bias. Validated outcome measures10-12, in-
cluding a visual analog scale, in which 0 indicated no pain and
10 indicated the worst possible pain, and pain diagrams show-
ing the location and quality of the pain, were used to docu-
ment pain levels. The Roland-Morris questionnaire10 and the
Oswestry low back pain disability questionnaire11 were used to
measure functional abilities. On the pre-procedure visual ana-
log scale, the patient rated maximal pain in the past twenty-
four hours. On the post-procedure visual analog scale, which
was administered by the radiologist between one and two
hours after the vertebroplasty, the patient was asked to rate the
pain that he or she was feeling at that time to document an
immediate clinical response to the procedure. The patient was
given discharge instructions, including recommendations for
follow-up with his or her primary care physician for os-
teoporosis management as well as an extension-based spine-
stabilization physical therapy program to increase comfort
and overcome the effects of the relative immobilization that
had been caused by the previous intractable pain.
Follow-up questionnaires were administered at two
weeks and at one, three, six, and twelve months after the pro-
cedure. Patients who were not responding to the procedure
and those in whom new pain developed were examined by one
of the surgeons or physiatrists, and radiographic imaging was
performed as directed by the patient’s history and findings on
physical examination. New vertebral compression fractures
were recorded. New pain was managed, according to the pa-
tient’s needs, with medications, rest, bracing, and physical
therapy. Patients in whom a new fracture developed indepen-
dently chose whether to undergo vertebroplasty for the subse-
quent fracture(s).
Statistical analyses were conducted to assess the effect of
vertebroplasty on pain, distress, and functional ability. The
variables assessed at baseline, two weeks, and one, three, six,
and twelve months were analyzed with a random coefficient
model created by PROC MIXED, from the SAS statistical soft-
ware package (SAS, Cary, North Carolina). The visual analog
score was the only variable assessed immediately following the
vertebroplasty, and it was not assessed at six or twelve months.
Because of the difference in the occasions for measurement
with the visual analog scale relative to the other variables, a
paired t test was used to assess the effect of vertebroplasty on
visual analog scale scores. A series of paired t tests was con-
ducted to determine the significance of the improvement in
individual items on the Roland-Morris questionnaire follow-
ing the vertebroplasty. Data regarding patients in whom new
fracture(s) developed after the vertebroplasty were analyzed
with the Fisher exact test.
Results
ifty patients, thirty-one women and nineteen men with a
mean age of 68.6 years (range, thirty-six to ninety-one
years), were followed prospectively for one year. Ten patients
died of causes unrelated to the vertebral fracture(s) prior to
the one-year follow-up date. All fifty patients had follow-up
data for six months, and forty were followed for one year. One
hundred and three fractures, including fifty-nine involving a
thoracic vertebra and forty-four involving a lumbar vertebra,
were treated. The mean duration of the pain prior to the pro-
cedure, as reported by the patients, was fourteen months
(range, one to seventy-two months). An average of 2.06 verte-
bral levels (range, one to four levels) was managed at each
treatment session. Only 39% of the patients could remember
the event that occurred at the time that the pain began. The
F
TABLE I Inclusion and Exclusion Criteria for Offering Vertebroplasty
Inclusion Criteria Exclusion Criteria
Intractable pain related to the compression fracture for ≥4 wk
No neurological compromise
Axial spine pain that worsens with active spine flexion
No other suspicious sources of pain as determined by imaging and 
clinical history
No laboratory evidence or history of a bleeding disorder
Patient determined to be medically stable for the procedure by 
primary care physician
Abnormal laboratory findings
Spine pain that did not clinically correlate with the vertebral fracture
Neurological compromise
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majority of the patients (61%) reported an insidious onset of
pain. Fifty-five percent of the patients had been diagnosed
with osteoporosis prior to the fracture for which they were be-
ing treated with the vertebroplasty. Forty-five percent of the
patients required a cane to walk, and 32% required a wheel-
chair for mobility in the community. Previous conservative
treatment had consisted of exercises for 14% of the patients,
bracing for 22%, and a spinal injection for 27%. All patients
were receiving a variety of medications for pain, including
nonsteroidal anti-inflammatory drugs, acetaminophen, tram-
adol, narcotics, gabapentin, tricyclic anti-depressants, and
muscle relaxants. The general health questionnaire revealed
that the patients had an average of 4.2 medical conditions
(range, one to eleven conditions).
Three patients had elected not to participate in the
study because they lived a distance from our center or they
were not willing to complete the questionnaires. No signifi-
cant differences regarding demographics were noted between
those who participated in the study and those who chose not
to participate. However, the group who chose to enroll in the
study reported, on the average, a longer duration of pain than
those who did not participate (Table II).
A total of fourteen new fractures developed in ten pa-
tients after the vertebroplasty. Nine of the new fractures were
within one or two vertebral levels cephalad or caudad to the
level that had been previously treated with the vertebroplasty,
and five new fractures were at levels remote from the previously
treated fracture. Seven of the ten patients elected to undergo an-
other vertebroplasty for treatment of the subsequent frac-
ture(s), and three patients chose conservative treatment. Of the
fifty patients treated, seven had received glucocorticosteroids
for various medical conditions prior to or at the time of the ver-
tebroplasty. New fracture(s) developed in all seven of those pa-
tients (a total of eight new fractures) after the vertebroplasty
(Table III). A Fisher exact test13 was used to calculate the exact
probability of obtaining the data pattern that we observed. A
chi-square test is typically used with a 2 × 2 table, but it was not
utilized in our analysis because of the zero value (representing
the fact that all patients who had taken steroids sustained a new
fracture) involved in the test. The obtained Fisher statistic was
25.46, which was highly significant (p = 0.0). Of the eight frac-
tures in the group of patients who had taken steroids, five were
at sites within one to two levels of the previously treated frac-
ture. Five of the seven patients elected to undergo another verte-
broplasty for treatment of the new fracture.
The visual analog scale showed significant improvement
(p < 0.0001) from a baseline mean of 7.76 ± 2.18 to an
immediate post-procedure mean of 3.1 ± 2.9. The visual analog
score remained improved (p < 0.0001) two weeks after the
procedure, with a mean of 3.7 ± 2.5; at four weeks after the pro-
cedure, with a mean of 2.9 ± 2.2; and at twelve weeks after the
procedure, with a mean of 2.9 ± 7.0. No significant changes
were found after the four-week measurement, as all scores re-
mained improved (mean at one year, 2.9).
The Oswestry low back pain disability questionnaire
and the Roland-Morris questionnaire (Fig. 1) demonstrated
significant (p < 0.0001) functional improvement from base-
line to one month after the procedure. With the numbers
available, there were no significant changes in any variable
from one month to one year (p > 0.05). A summary of the re-
sults of the paired t tests for the individual items on the Ro-
land-Morris questionnaire is presented in Table IV. Sixty-nine
t tests were conducted (13 items × 3 comparisons). A p value
of 0.005 was selected as a cutoff for significance, and p values
between 0.05 and 0.005 were considered to be marginally sig-
nificant. The activities on the Roland-Morris questionnaire
TABLE III 2 × 2 Contingency Table of Number of Subjects Taking and Not Taking Steroids Who Did and Did Not Sustain a 
Refracture
Taking Steroids Not Taking Steroids Total
Refracture 7 3 10
No refracture 0 40 40
Total 7 43 50
TABLE II Comparison of Demographic Information Between Study Participants and Nonparticipants
Participants* (N = 50) Nonparticipants* (N = 3)
Mean age (yr) 68.6 (36-91) 74 (57-88)
Gender 31 F, 19 M 2 F, 1 M
Mean no. of medications 1.6 (1-2) 1.6 (1-2)
Mean no. of fractures 2.06 (1-4) 2.6 (2-3)
Mean no. of comorbidities 4.2 (1-11) 4 (3-6)
Mean pain duration (mo) 14 (1-72) 7.6 (7-9)
*The numbers in parentheses indicate the range.
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that showed the most significant improvement were transfers
in and out of bed, standing, sleeping, and sitting, with p values
of <0.0001 for the comparison between baseline and one
month, 0.005 to <0.0001 for the comparison between base-
line and three months, and 0.0008 to <0.0001 for the compar-
ison between baseline and six months. Functions that did not
improve significantly (p > 0.05) following vertebroplasty were
toileting, lifting heavy objects, participation in hobbies, and
strenuous housework.
Ten of the fifty patients died after the six-month follow-
up examination and prior to the one-year follow-up date.
None of the deaths were thought to be related to the vertebro-
plasty. The patients ranged in age from seventy-five to eighty-
seven years old at the time of death. A series of graphs was cre-
ated to examine the potential effect of the missing data on the
results (Figs. 2-A and 2-B). Because of their similarity and the
small standard error bars, these graphs suggested that the ob-
served pattern of improvement following vertebroplasty was
unlikely to have been an artifact of missing data.
Discussion
ercutaneous vertebroplasty is becoming more popular for
treating patients with osteoporotic vertebral compression
fractures. In the current study, we evaluated outcomes of verte-
broplasty in patients with intractable pain due to osteoporotic
vertebral compression fracture(s) for which comprehensive
conservative management had failed. The conservative manage-
ment varied and was based on the patient’s condition and the
primary treating physician’s preferences for therapeutic modali-
ties. In general, this group of patients had complex conditions,
with a mean of 4.2 other reported medical problems, reduced
mobility, and an average fourteen-month duration of pain be-
fore the vetebroplasty procedure. Patients were offered verte-
broplasty on the basis of a multidisciplinary physician review.
No adverse events were recorded as a result of the proce-
dure in the fifty patients in this study. The results indicate a
clear improvement in function and decrease in pain within two
weeks after the procedure. There were no additional significant
improvements with regard to pain relief or function after three
months, as demonstrated by the Roland-Morris and Oswestry
questionnaires. However, the improvements acquired in the
P
Fig. 1
Mean scores (with standard error bars) according to the Roland-Morris questionnaire and 
the Oswestry low back pain disability questionnaire at baseline, two weeks, one month, 
three months, six months, and twelve months after the vertebroplasty.
TABLE IV Functional Activities with and without 
Significant Improvement as Measured with 
the Roland-Morris Questionnaire
Activities with Most 
Significant Improvement* 
Activities with No 
Significant Improvement†




Dressing Lifting heavy objects
Shopping Participation in hobbies
Bathing Strenuous housework
*P < 0.0001. †P > 0.005. 
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first three months were maintained at six and twelve months.
The patient’s perceptions of pain and functional improvement
were evaluated with validated prospective questionnaires rather
than a global assessment by the treating physician or measure-
ment of outcome at just one point in time. The results indicate
that vertebroplasty has a significant beneficial impact on func-
tion and pain, with the benefits continuing at six months and
one year. We can infer from these results that decreased pain
and improved mobility have the potential to reduce morbidity
and should reduce long-term health-care costs.
The functional activities that showed significant im-
provement were basic tasks required to maintain independent
living. Only one item that is a basic requirement for indepen-
dent living, toileting, did not improve. We speculated that a
person must have substantial proximal strength to perform
toileting independently. Many of our patients were quite de-
bilitated, partly as a result of inactivity and decreased mobility
secondary to the pain that they had experienced prior to the
vertebroplasty. As a result, we recommend that basic activities
of daily living be evaluated and physical therapy be started,
when indicated, after vertebroplasty.
All of the patients who had taken glucocorticosteroids
sustained a new fracture after the vertebroplasty. Although new
fractures are a known risk of vertebroplasty4,5,8,14-16, the etiologies
are multifactorial and have not been entirely identified. These
factors include dynamic mobility of the fracture17, location of
the new fracture adjacent to the treated vertebra14,18, cement ex-
travasation at the time of the procedure16, and the type of and
amount of filling by the cement19-21. To our knowledge, the ex-
tent of the osteoporosis and previous treatment to improve
bone metabolism and musculoskeletal fitness have not been
evaluated as factors contributing to the development of new
fractures. In a study by Uppin et al.14, new fractures developed
in twenty-two (12.4%) of 177 patients after treatment with ver-
tebroplasty. Sixty-seven percent of thirty-six new fractures
were at a level adjacent to the vertebral body that had been
treated, and 67% of the fractures occurred within thirty days
after the initial vertebroplasty. Uppin et al. focused primarily
Fig. 2-A
Mean scores (with standard error bars) according to the Roland-Morris 
questionnaire (averaged across items), at baseline, two weeks, one 
month, three months, six months, and twelve months after the verte-
broplasty. Top: Scores for all fifty patients, including those who died 
prior to the twelve-month follow-up date. Bottom: Scores for forty 
patients—that is, not including those who died prior to the twelve-
month follow-up date.
Fig. 2-B
Mean scores (with standard error bars) according to the Oswestry low 
back pain disability questionnaire (averaged across items), at baseline, 
two weeks, one month, three months, six months, and twelve months 
after the vertebroplasty. Top: Scores for all fifty patients, including 
those who died prior to the twelve-month follow-up date. Bottom: 
Scores for forty patients—that is, not including those who died prior to 
the twelve-month follow-up date.
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on identifying the location of subsequent fractures, and they
reported information only on patients who returned for addi-
tional interventions. It is possible that patients who sustained
subsequent fractures but did not seek procedural intervention
were not included. Seven (32%) of the twenty-two patients
who returned for a procedure to treat a new fracture in that
study had steroid-induced osteoporosis. In a study by Perez-
Higueras et al.5, three of thirteen patients sustained a new
fracture, and two of the three elected to be treated with verte-
broplasty again. In a study by Lindsay et al.22, women with
osteoporosis who had not been treated with verteboplasty and
who had sustained one fracture had a 19.2% prevalence of an
additional fracture within a year. Therefore, it can be reason-
ably assumed that some of the fractures that occurred after the
vertebroplasties in our study would have occurred if a verte-
broplasty had not been performed.
To our knowledge, the risk of a new vertebral body col-
lapse following a vertebroplasty in patients with steroid-induced
osteoporosis has not been studied. Initially, glucocorticosteroids
affect trabecular bone by causing a high rate of surface resorp-
tion and high bone-turnover rate. As a result, glucocortico-
steroids are associated with a four to fivefold increase in the
prevalence of vertebral fracture as compared with the prevalence
in patients who are not treated with corticosteroids23. Two
studies24,25 have suggested that patients with vertebral fractures
due to corticosteroids have higher bone-mineral-density values
than those with fractures due to other forms of osteoporosis. Re-
hman et al.26 found that bone mineral density measured with
quantitative computed tomography, but not with dual-energy x-
ray absorptiometry, was an independent predictor of vertebral
fractures in postmenopausal women with steroid-induced os-
teoporosis. With this in mind, patients offered vertebroplasty for
compression fractures due to steroid-induced osteoporosis
should be counseled on the probable additional risk of a new
fracture after the vertebroplasty.
This study had several weaknesses. Ten of the fifty pa-
tients died before the one-year follow-up date, which resulted
in missing data after six months. Also, although physical
therapy was prescribed for all patients, compliance was not
measured. Forty-five percent of the patients had not been di-
agnosed with osteoporosis prior to the vertebral fracture, indi-
cating that osteoporosis continues to be a silent entity. The
medical management was determined by the primary care
physician and, if necessary, the patient was referred to the
bone-mineral-health service at our center. As a result, medical
management varied within the group. We did not include a
control group for comparison, as optimal conservative care
had failed for all patients. However, we thought that offering
no treatment (as a control) to a group of patients with intrac-
table pain was clinically unacceptable. Instead, this study
served to demonstrate pain relief and improvement in func-
tional outcomes in patients for whom conservative manage-
ment had failed.
In this study, we reported on the utility of vertebro-
plasty. Kyphoplasty, a procedure that includes inflating a per-
cutaneously placed balloon within the fractured vertebra and
then infusing cement within the cavity created by the balloon,
has not been studied. Our study included only outpatients for
whom previous treatment had failed, who elected to undergo
vertebroplasty, and who agreed to be followed for one year. To
our knowledge, no studies have been performed to compare
the benefits of vertebroplasty with those of kyphoplasty in hu-
mans with non-neoplastic fractures27. Our study focused on
patients with pain for whom conservative management had
failed and who had few or no remaining therapeutic options
other than vertebroplasty. In this population, vertebroplasty
significantly decreased pain and improved function. Future
prospective studies are needed to compare standard conserva-
tive treatment with vertebroplasty and with kyphoplasty. Ad-
ditional studies are also needed to better determine the risk
factors for the development of new fractures after vertebro-
plasty and to verify that the rate of incidental fractures after
vertebroplasty is actually higher than what occurs in a popula-
tion without vertebroplasty. 
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